nedaplatin has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Gu, J; Guo, W; He, X; Jiang, X; Wang, D; Wang, X; Wu, J; Xu, L; Ye, J; Yin, L; Zhang, J; Zong, D | 1 |
1 other study(ies) available for nedaplatin and EBV Infections
| Article | Year |
|---|---|
Radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of Epstein-Barr virus infection.
Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Epstein-Barr Virus Infections; G2 Phase Cell Cycle Checkpoints; Herpesvirus 4, Human; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Radiation Tolerance; Radiation-Sensitizing Agents | 2014 |